Related MeSH Hierarchy (5)
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Body Weight
Analytical, Diagnostic and Therapeutic Techniques, and Equipment [E] » Diagnosis [E01] » Diagnostic Techniques and Procedures » Physical Examination » Body Constitution » Body Weights and Measures » Body Size » Body Weight
Analytical, Diagnostic and Therapeutic Techniques, and Equipment [E] » Investigative Techniques [E05] » Anthropometry » Body Weights and Measures » Body Size » Body Weight
Phenomena and Processes [G] » Physiological Phenomena [G07] » Body Constitution » Body Weights and Measures » Body Size » Body Weight
Phenomena and Processes [G] » Physiological Phenomena [G07] » Growth and Development » Growth » Body Size » Body Weight
Description
The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. MeSH
Hierarchy View
Subtype Terms (7)
Birth Weight
9 drugs (6 approved, 3 experimental)
Body Weight Changes
43 drugs (25 approved, 18 experimental)
Ideal Body Weight
2 drugs (1 approved, 1 experimental)
Overweight
197 drugs (57 approved, 140 experimental)
Thinness
4 drugs (3 approved, 1 experimental)
Phase 4 Indicated Drugs (15)
Phase 3 Indicated Drugs (6)
Phase 2 Indicated Drugs (17)
Phase 1 Indicated Drugs (6)
Other Experimental Indicated Drugs (24)
Organization Involved with Phase 4 Indications (42)
Organization Involved with Phase 3 Indications (52)
Canadian Center for Functional Medicine
Case Western Reserve University
Groupement de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso
Istituto Clinico Humanitas - Rozzano (MI), Italy
J.O. Odinga Hospital, Kisumu, Kenya
Nanyang Technological University
National Cancer Institute (NCI)
National Institute of Child Health and Human Development (NICHD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Pennington Biomedical Research Center
Saint John Hospital & Medical Center
University of Alabama, Birmingham
Organization Involved with Phase 2 Indications (49)
International Antiviral Therapy Evaluation Center (IATEC)
Midwest Institute for Clinical Research
National Center for Complementary and Integrative Health (NCCIH)
National Center for Research Resources (NCRR)
Organization Involved with Phase 1 Indications (11)
Organization Involved with Other Experimental Indications (87)
All India Institute of Medical Sciences
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Dr. Sulaiman Alhabib Medical City, Riyadh
Federal University of Rio de Janeiro
German Diabetes Foundation, Munich, Germany
German Institute of Human Nutrition
Indonesian Directorate General of Higher Education
Justus Liebig University Giessen
King Faisal Specialist Hospital
Klinikum Ernst von Bergmann Augenklinik Laserzentrum
Linda and Kenneth Pollin Foundation, Inc.
National University of Singapore
Rio de Janeiro State University
Society for Applied Studies, New Delhi
Swiss Federal Institute of Technology
TERME DI CHIANCIANO Spa, Italy
Top Institute Food and Nutrition
United States Department of Agriculture
Universidad Autonoma de Madrid
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
